|
AU2003252765B2
(en)
*
|
1999-02-05 |
2006-06-29 |
Samsung Electronics Co., Ltd. |
Image texture retrieving method and apparatus thereof
|
|
KR100308456B1
(ko)
*
|
1999-07-09 |
2001-11-02 |
오길록 |
주파수 공간상에서의 질감표현방법 및 질감기반 검색방법
|
|
KR100355404B1
(ko)
*
|
1999-12-03 |
2002-10-11 |
삼성전자 주식회사 |
주파수 공간상에서의 가보 필터를 이용한 질감표현방법 및질감기반 영상 검색방법
|
|
US6977659B2
(en)
*
|
2001-10-11 |
2005-12-20 |
At & T Corp. |
Texture replacement in video sequences and images
|
|
US7606435B1
(en)
|
2002-02-21 |
2009-10-20 |
At&T Intellectual Property Ii, L.P. |
System and method for encoding and decoding using texture replacement
|
|
KR100908384B1
(ko)
*
|
2002-06-25 |
2009-07-20 |
주식회사 케이티 |
블록상관계수를 이용한 영역기반 질감 추출 장치 및 그 방법
|
|
JP2005122361A
(ja)
*
|
2003-10-15 |
2005-05-12 |
Sony Computer Entertainment Inc |
画像処理装置及び方法、コンピュータプログラム、記録媒体
|
|
US7415145B2
(en)
*
|
2003-12-30 |
2008-08-19 |
General Electric Company |
Methods and apparatus for artifact reduction
|
|
JP4747881B2
(ja)
*
|
2006-02-27 |
2011-08-17 |
セイコーエプソン株式会社 |
演算処理装置によるデータ変換方法、テクスチャの作成方法、プログラム、記録媒体、及びプロジェクタ。
|
|
EP2433650A3
(de)
*
|
2006-06-06 |
2012-12-19 |
Tolerrx Inc. |
Verabreichung von Anti-CD3-Antikörpern zur Behandlung von Autoimmunerkrankungen
|
|
EP1870836A1
(de)
*
|
2006-06-22 |
2007-12-26 |
THOMSON Licensing |
Verfahren und Vorrichtung zur Bestimmung eines Deskriptors für ein Signal, das ein Multimedia-Element darstellt, Vorrichtung zur Gewinnung von Elementen in einer Datenbank, Vorrichtung zur Klassifizierung von Multimedia-Elementen in einer Datenbank
|
|
JP5358083B2
(ja)
*
|
2007-11-01 |
2013-12-04 |
株式会社日立製作所 |
人物画像検索装置及び画像検索装置
|
|
US7924290B2
(en)
*
|
2007-05-30 |
2011-04-12 |
Nvidia Corporation |
Method and system for processing texture samples with programmable offset positions
|
|
KR101394154B1
(ko)
*
|
2007-10-16 |
2014-05-14 |
삼성전자주식회사 |
미디어 컨텐츠 및 메타데이터를 부호화하는 방법과 그 장치
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
US20140321756A9
(en)
*
|
2008-05-27 |
2014-10-30 |
Samsung Electronics Co., Ltd. |
System and method for circling detection based on object trajectory
|
|
US8483431B2
(en)
|
2008-05-27 |
2013-07-09 |
Samsung Electronics Co., Ltd. |
System and method for estimating the centers of moving objects in a video sequence
|
|
US8107726B2
(en)
*
|
2008-06-18 |
2012-01-31 |
Samsung Electronics Co., Ltd. |
System and method for class-specific object segmentation of image data
|
|
US20100027845A1
(en)
*
|
2008-07-31 |
2010-02-04 |
Samsung Electronics Co., Ltd. |
System and method for motion detection based on object trajectory
|
|
US8433101B2
(en)
*
|
2008-07-31 |
2013-04-30 |
Samsung Electronics Co., Ltd. |
System and method for waving detection based on object trajectory
|
|
US8073818B2
(en)
*
|
2008-10-03 |
2011-12-06 |
Microsoft Corporation |
Co-location visual pattern mining for near-duplicate image retrieval
|
|
KR101194605B1
(ko)
*
|
2008-12-22 |
2012-10-25 |
한국전자통신연구원 |
시간 연속적 텍스쳐 합성 장치 및 방법
|
|
KR101028628B1
(ko)
|
2008-12-29 |
2011-04-11 |
포항공과대학교 산학협력단 |
영상 텍스쳐 필터링 방법, 이를 수행하는 프로그램을 기록한 기록매체 및 이를 수행하는 장치
|
|
US8321422B1
(en)
|
2009-04-23 |
2012-11-27 |
Google Inc. |
Fast covariance matrix generation
|
|
US8611695B1
(en)
|
2009-04-27 |
2013-12-17 |
Google Inc. |
Large scale patch search
|
|
US8396325B1
(en)
|
2009-04-27 |
2013-03-12 |
Google Inc. |
Image enhancement through discrete patch optimization
|
|
US8391634B1
(en)
*
|
2009-04-28 |
2013-03-05 |
Google Inc. |
Illumination estimation for images
|
|
US8385662B1
(en)
|
2009-04-30 |
2013-02-26 |
Google Inc. |
Principal component analysis based seed generation for clustering analysis
|
|
US8798393B2
(en)
|
2010-12-01 |
2014-08-05 |
Google Inc. |
Removing illumination variation from images
|
|
EP2648752B1
(de)
|
2010-12-06 |
2017-02-15 |
Seattle Genetics, Inc. |
Humanisierte antikörper gegen liv-1 und verwendung davon zur behandlung von krebs
|
|
US8738280B2
(en)
*
|
2011-06-09 |
2014-05-27 |
Autotalks Ltd. |
Methods for activity reduction in pedestrian-to-vehicle communication networks
|
|
RS63930B1
(sr)
|
2011-10-28 |
2023-02-28 |
Prothena Biosciences Ltd |
Humanizovana antitela koja prepoznaju alfa-sinuklein
|
|
DK2807188T3
(da)
|
2012-01-27 |
2019-10-07 |
Prothena Biosciences Ltd |
Humaniserede antistoffer, der genkender alpha-synuclein
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
UA118441C2
(uk)
|
2012-10-08 |
2019-01-25 |
Протена Біосаєнсиз Лімітед |
Антитіло, що розпізнає альфа-синуклеїн
|
|
US10501531B2
(en)
|
2013-03-13 |
2019-12-10 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
US10513555B2
(en)
|
2013-07-04 |
2019-12-24 |
Prothena Biosciences Limited |
Antibody formulations and methods
|
|
US9850302B2
(en)
|
2013-07-12 |
2017-12-26 |
Prothena Biosciences Limited |
Antibodies that recognize IAPP
|
|
WO2015004633A1
(en)
|
2013-07-12 |
2015-01-15 |
Neotope Biosciences Limited |
Antibodies that recognize islet-amyloid polypeptide (iapp)
|
|
KR101713690B1
(ko)
*
|
2013-10-25 |
2017-03-08 |
한국전자통신연구원 |
특징 선택 방법을 이용한 비주얼 기술자 추출 방법 및 시스템
|
|
JP2017501848A
(ja)
|
2013-11-19 |
2017-01-19 |
プロセナ バイオサイエンシーズ リミテッド |
便秘症状からのレビー小体病の免疫療法のモニター
|
|
TW201623331A
(zh)
|
2014-03-12 |
2016-07-01 |
普羅帝納生物科學公司 |
抗黑色素瘤細胞黏著分子(mcam)抗體類及使用彼等之相關方法
|
|
PT3116911T
(pt)
|
2014-03-12 |
2019-09-04 |
Prothena Biosciences Ltd |
Anticorpos anti-mcam e métodos de utilização associados
|
|
KR20160131082A
(ko)
|
2014-03-12 |
2016-11-15 |
프로테나 바이오사이언시즈 리미티드 |
Lg1-3에 특이적인 항-라미닌4 항체
|
|
JP2017514458A
(ja)
|
2014-03-12 |
2017-06-08 |
プロセナ バイオサイエンシーズ リミテッド |
Lg4−5に対して特異的な抗−ラミニン4抗体
|
|
KR20170052526A
(ko)
|
2014-03-13 |
2017-05-12 |
프로테나 바이오사이언시즈 리미티드 |
다발성 경화증에 대한 병용 치료
|
|
CA2944402A1
(en)
|
2014-04-08 |
2015-10-15 |
Prothena Biosciences Limited |
Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein
|
|
US9840553B2
(en)
|
2014-06-28 |
2017-12-12 |
Kodiak Sciences Inc. |
Dual PDGF/VEGF antagonists
|
|
KR102260805B1
(ko)
*
|
2014-08-06 |
2021-06-07 |
삼성전자주식회사 |
이미지 검색 장치 및 그 방법
|
|
US20160075772A1
(en)
|
2014-09-12 |
2016-03-17 |
Regeneron Pharmaceuticals, Inc. |
Treatment of Fibrodysplasia Ossificans Progressiva
|
|
KR102258100B1
(ko)
*
|
2014-11-18 |
2021-05-28 |
삼성전자주식회사 |
텍스쳐 처리 방법 및 장치
|
|
TWI769570B
(zh)
|
2015-01-28 |
2022-07-01 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
|
TWI718121B
(zh)
|
2015-01-28 |
2021-02-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
|
TWI786505B
(zh)
|
2015-01-28 |
2022-12-11 |
愛爾蘭商普羅佘納生物科技有限公司 |
抗甲狀腺素運送蛋白抗體
|
|
EP3288976B1
(de)
|
2015-04-29 |
2020-04-08 |
Regeneron Pharmaceuticals, Inc. |
Behandlung von fibrodysplasia ossificans progressiva
|
|
US10162878B2
(en)
|
2015-05-21 |
2018-12-25 |
Tibco Software Inc. |
System and method for agglomerative clustering
|
|
WO2016197307A1
(en)
|
2015-06-08 |
2016-12-15 |
SZ DJI Technology Co., Ltd. |
Methods and apparatus for image processing
|
|
KR101627974B1
(ko)
*
|
2015-06-19 |
2016-06-14 |
인하대학교 산학협력단 |
영상 블러에 강인한 영상 특징 기술자 생성 방법 및 장치
|
|
SG10202005460RA
(en)
|
2015-06-30 |
2020-07-29 |
Seattle Genetics Inc |
Anti-ntb-a antibodies and related compositions and methods
|
|
CN105183752B
(zh)
*
|
2015-07-13 |
2018-08-10 |
中国电子科技集团公司第十研究所 |
关联查询红外视频图像特定内容的方法
|
|
EP3350226A2
(de)
|
2015-09-16 |
2018-07-25 |
Prothena Biosciences Limited |
Verwendung von anti-mcam-antikörpern zur behandlung oder prophylaxe von riesenzellarteriitis, polymyalgia rheumatica oder takayasu-arteriitis
|
|
WO2017046774A2
(en)
|
2015-09-16 |
2017-03-23 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis
|
|
KR20250057128A
(ko)
|
2015-12-30 |
2025-04-28 |
코디악 사이언시스 인코포레이티드 |
항체 및 이의 접합체
|
|
CN108778329B
(zh)
|
2016-02-17 |
2022-09-16 |
西雅图基因公司 |
Bcma抗体和其用以治疗癌症和免疫病症的用途
|
|
WO2017149513A1
(en)
|
2016-03-03 |
2017-09-08 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
|
US10537633B2
(en)
|
2016-03-04 |
2020-01-21 |
Jn Biosciences Llc |
Antibodies to TIGIT
|
|
WO2017153953A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
|
WO2017153955A1
(en)
|
2016-03-09 |
2017-09-14 |
Prothena Biosciences Limited |
Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases
|
|
MX2018013386A
(es)
|
2016-05-02 |
2019-02-28 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau.
|
|
PT3452507T
(pt)
|
2016-05-02 |
2022-12-20 |
Prothena Biosciences Ltd |
Imunoterapia anti-tau
|
|
MY198194A
(en)
|
2016-05-02 |
2023-08-09 |
Prothena Biosciences Ltd |
Antibodies Recognizing Tau
|
|
WO2017208210A1
(en)
|
2016-06-03 |
2017-12-07 |
Prothena Biosciences Limited |
Anti-mcam antibodies and associated methods of use
|
|
WO2018007924A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
WO2018007922A2
(en)
|
2016-07-02 |
2018-01-11 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
JP7016470B2
(ja)
|
2016-07-02 |
2022-02-07 |
プロセナ バイオサイエンシーズ リミテッド |
抗トランスサイレチン抗体
|
|
CA3059938A1
(en)
|
2017-04-14 |
2018-10-18 |
Kodiak Sciences Inc. |
Complement factor d antagonist antibodies and conjugates thereof
|
|
KR102784294B1
(ko)
|
2017-05-02 |
2025-03-19 |
프로테나 바이오사이언시즈 리미티드 |
타우 인식 항체
|
|
WO2019064053A1
(en)
|
2017-09-28 |
2019-04-04 |
Prothena Biosciences Limited |
DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES
|
|
AU2018345807B2
(en)
|
2017-10-06 |
2025-02-06 |
Novo Nordisk A/S |
Methods of detecting transthyretin
|
|
PE20211453A1
(es)
|
2017-11-29 |
2021-08-05 |
Prothena Biosciences Ltd |
Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina
|
|
EP3508499A1
(de)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Antikörper zum targeting von, und andere modulatoren von, einem immunglobulingen im zusammenhang mit resistenz gegen antitumor-immunantworten und verwendungen davon
|
|
EP3758737A4
(de)
|
2018-03-02 |
2022-10-12 |
Kodiak Sciences Inc. |
Il-6-antikörper und fusionskonstrukte und konjugate davon
|
|
TWI851577B
(zh)
|
2018-06-07 |
2024-08-11 |
美商思進公司 |
喜樹鹼結合物
|
|
JP2021534196A
(ja)
|
2018-08-23 |
2021-12-09 |
シージェン インコーポレイテッド |
抗tigit抗体
|
|
CU24781B1
(es)
|
2018-11-08 |
2026-02-09 |
Prothena Biosciences Ltd |
Anticuerpos humanizados que reconocen tau
|
|
EA202190986A1
(ru)
|
2018-11-26 |
2021-12-14 |
Фоти Севен, Инк. |
ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К c-Kit
|
|
EP3886869A4
(de)
|
2018-11-28 |
2022-07-06 |
Forty Seven, Inc. |
Genetisch modifizierte ablationsresistente hspcs
|
|
CN109670423A
(zh)
*
|
2018-12-05 |
2019-04-23 |
依通(北京)科技有限公司 |
一种基于深度学习的图像识别系统、方法及介质
|
|
WO2020163225A1
(en)
|
2019-02-05 |
2020-08-13 |
Seattle Genetics, Inc. |
Anti-cd228 antibodies and antibody-drug conjugates
|
|
JP7630834B2
(ja)
|
2019-03-03 |
2025-02-18 |
プロセナ バイオサイエンシーズ リミテッド |
タウ認識抗体
|
|
KR20220051164A
(ko)
|
2019-07-05 |
2022-04-26 |
아이오엠엑스 테라퓨틱스 아게 |
Igsf11 (vsig3)의 항체 결합 igc2 및 이의 용도
|
|
EP4038101A2
(de)
|
2019-10-04 |
2022-08-10 |
Seagen Inc. |
Anti-pd-l1-antikörper und antikörperwirkstoffkonjugate
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
EP3822288A1
(de)
|
2019-11-18 |
2021-05-19 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Gegen das cd276-antigen gerichtete antikörper, und andere modulatoren gegen das cd276-antigen, und deren verwendung
|
|
CN115243763A
(zh)
|
2020-01-08 |
2022-10-25 |
里珍纳龙药品有限公司 |
治疗进行性骨化性纤维发育不良
|
|
EP4126952A1
(de)
|
2020-03-26 |
2023-02-08 |
Seagen Inc. |
Verfahren zur behandlung von multiplem myelom
|
|
MX2022015157A
(es)
|
2020-06-02 |
2023-01-16 |
Arcus Biosciences Inc |
Anticuerpos para tigit.
|
|
EP4175668A1
(de)
|
2020-07-06 |
2023-05-10 |
iOmx Therapeutics AG |
Igv von igsf11 (vsig3) bindende antikörper und verwendungen davon
|
|
KR20230039734A
(ko)
|
2020-07-23 |
2023-03-21 |
오타이르 프로테나 리미티드 |
항-Aβ 항체
|
|
KR20230042518A
(ko)
|
2020-08-04 |
2023-03-28 |
씨젠 인크. |
항-cd228 항체 및 항체-약물 컨쥬게이트
|
|
AU2021374803A1
(en)
|
2020-11-03 |
2023-06-22 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Target-cell restricted, costimulatory, bispecific and bivalent anti-cd28 antibodies
|
|
JP2024504493A
(ja)
|
2021-01-28 |
2024-01-31 |
ヴァクスィーンヴェント ゲーエムベーハー |
B細胞媒介性免疫応答を調節するための方法及び手段
|
|
CN117120084A
(zh)
|
2021-01-28 |
2023-11-24 |
维肯芬特有限责任公司 |
用于调节b细胞介导的免疫应答的方法和手段
|
|
WO2022162203A1
(en)
|
2021-01-28 |
2022-08-04 |
Vaccinvent Gmbh |
Method and means for modulating b-cell mediated immune responses
|
|
EP4320160A1
(de)
|
2021-04-09 |
2024-02-14 |
Seagen Inc. |
Verfahren zur behandlung von krebs mit anti-tigit-antikörpern
|
|
TW202327650A
(zh)
|
2021-09-23 |
2023-07-16 |
美商思進公司 |
治療多發性骨髓瘤之方法
|
|
CA3256048A1
(en)
|
2022-04-13 |
2023-10-19 |
Arcus Biosciences, Inc. |
POLYTHERAPY FOR THE TREATMENT OF CANCERS EXPRESSING A TUMOR ANTIGEN
|
|
JP2025512384A
(ja)
|
2022-04-13 |
2025-04-17 |
ギリアード サイエンシーズ, インコーポレイテッド |
Trop-2発現がんを治療するための併用療法
|
|
AU2023264591A1
(en)
|
2022-05-02 |
2024-11-07 |
Arcus Biosciences, Inc. |
Anti-tigit antibodies and uses of the same
|
|
EP4594483A1
(de)
|
2022-09-28 |
2025-08-06 |
Deutsches Krebsforschungszentrum |
Modifizierte ace2-proteine mit verbesserter aktivität gegen sars-cov-2
|
|
KR20250089558A
(ko)
|
2022-11-03 |
2025-06-18 |
씨젠 인크. |
항-αvβ6 항체 및 항체-약물 접합체 및 암 치료에서의 이의 용도
|
|
EP4619045A1
(de)
|
2022-11-17 |
2025-09-24 |
Sanofi |
Ceacam5-antikörper-wirkstoff-konjugate und verfahren zur verwendung davon
|
|
AU2023410277A1
(en)
|
2022-12-23 |
2025-06-12 |
Iomx Therapeutics Ag |
Cross-specific antigen binding proteins (abp) targeting leukocyte immunoglobulin-like receptor subfamily b1 (lilrb1) and lilrb2, combinations and uses thereof
|
|
EP4491230A1
(de)
|
2023-07-14 |
2025-01-15 |
iOmx Therapeutics AG |
Gegen leukozyten-immunglobulin-lirb1 (lilrb1) und lilrb2, gerichtete kreuzspezifische antigenbindende proteine (abp) und verwendungen davon
|
|
TW202434629A
(zh)
|
2023-01-26 |
2024-09-01 |
愛爾蘭商歐薩爾普羅席納有限公司 |
以抗類澱粉β (ABETA)抗體治療神經病症之方法
|
|
WO2024191807A1
(en)
|
2023-03-10 |
2024-09-19 |
Seagen Inc. |
Methods of treating cancer with anti-tigit antibodies
|
|
WO2024249894A2
(en)
|
2023-06-02 |
2024-12-05 |
Arcus Biosciences, Inc. |
Biomarkers for predicting cancer treatment efficacy
|
|
TW202530246A
(zh)
|
2023-09-15 |
2025-08-01 |
愛爾蘭商歐賽爾普羅希那有限公司 |
細胞穿透劑及其用途
|
|
AR133834A1
(es)
|
2023-09-15 |
2025-11-05 |
Prothena Biosciences Ltd |
Agentes de penetración célular y sus usos
|
|
WO2025059486A1
(en)
|
2023-09-15 |
2025-03-20 |
Prothena Biosciences Limited |
Anti-tdp-43 antibodies and uses thereof
|
|
TW202545567A
(zh)
|
2024-01-30 |
2025-12-01 |
美商思進公司 |
抗pd-l1抗體和抗體-藥物共軛體及彼等在治療癌症的用途
|
|
WO2025196639A1
(en)
|
2024-03-21 |
2025-09-25 |
Seagen Inc. |
Cd25 antibodies, antibody-drug conjugates, and uses thereof
|
|
WO2026003224A2
(en)
|
2024-06-26 |
2026-01-02 |
Iomx Therapeutics Ag |
Bispecific antigen binding proteins (abp) targeting immune checkpoint molecules and both leukocyte immunoglobulin-like receptor subfamily b1 (lilrb1) and lilrb2; combinations and uses thereof
|
|
WO2026055669A2
(en)
|
2024-09-09 |
2026-03-12 |
Xencor, Inc. |
Anti-tl1a x anti-il23 antibodies
|